Implantable Pressure Sensor Market Report 2026

Implantable Pressure Sensor Market Overview

• Implantable Pressure Sensor market size has reached to $4.22 billion in 2025 • Expected to grow to $7.37 billion in 2030 at a compound annual growth rate (CAGR) of 11.8% • Growth Driver: Surge In Cardiovascular Diseases Fueling The Growth Of The Market Due To Rising Sedentary Lifestyles And Heart-related Health Risks • Market Trend: Next-Generation Implantable Device Transforms Glaucoma Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Implantable Pressure Sensor Market?

An implantable pressure sensor is a medical device designed to be placed inside the body to continuously monitor internal pressure within organs or blood vessels. It converts physiological pressure into electrical signals that can be measured and analyzed for clinical or research purposes. These sensors enable real-time monitoring and provide accurate data to support medical assessments and treatment decisions. The main products of implantable pressure sensor include wireless implantable pressure sensors and wired implantable pressure sensors. Wireless implantable pressure sensors are devices designed to monitor internal pressure within the body, providing real-time data to improve patient management and clinical outcomes. They are based on technologies such as microelectromechanical systems (MEMS), fiber optic, and other technologies. The various applications involved are cardiovascular, neurology, urology, intraocular, and other applications, and they are used by several end users such as hospitals, ambulatory surgical centers, specialty clinics, and other end-users.

What Is The Implantable Pressure Sensor Market Growth Forecast?

The implantable pressure sensor market size is expected to see rapid growth in the next few years. It will grow to $7.37 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to growing adoption of remote patient monitoring, increasing integration with digital health platforms, rising demand for personalized treatment solutions, expanding geriatric population, increasing investment in implantable medical device R&D. Major trends in the forecast period include increasing adoption of wireless implantable pressure sensors, rising demand for continuous real time internal monitoring, growing miniaturization of implantable sensor devices, expansion of minimally invasive implantation procedures, rising clinical use in cardiovascular and neurological applications.

What Is The Driver Of The Implantable Pressure Sensor Market?

The increasing prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the implantable pressure sensor market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including conditions such as heart failure, coronary artery disease, hypertension, and stroke. The rising burden of CVDs is largely driven by sedentary lifestyles, which contribute to obesity, elevated blood pressure, and an increased risk of heart-related complications. Implantable pressure sensors play a critical role in the management of cardiovascular diseases by enabling continuous monitoring of intracardiac or arterial pressure, particularly in patients with chronic conditions such as heart failure. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based national public health agency that cardiovascular disease caused 919,032 deaths in the US about 1 in 3 with roughly 805,000 heart attacks, including 605,000 first-time and 200,000 repeat cases. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the implantable pressure sensor industry.

Key Players In The Global Implantable Pressure Sensor Market

Major companies operating in the implantable pressure sensor market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., TE Connectivity Ltd, Analog Devices Inc., Keller America Inc., ICU Medical Inc., Integra LifeSciences Holdings Corporation, Raumedic AG, Endotronix Inc., Sophysa SA, Silex Microsystems AB, Millar Inc., Spiegelberg GmbH Co. KG, InjectSense Inc., Implandata Ophthalmic Products GmbH, Opsens Inc, MEMSCAP S.A., Aesculap Miethke GmbH Co. KG, First Sensor AG.

Global Implantable Pressure Sensor Market Trends and Insights

Major companies operating in the implantable pressure sensor market are increasingly focusing on developing innovative implantable devices that enable continuous, real-time intraocular pressure (IOP) monitoring to improve patient outcomes in glaucoma management. Implantable devices are medical technologies designed to be placed inside the body to monitor, support, or treat physiological functions over extended periods. For instance, in August 2024, Injectsense Inc., a US-based medical device company, announced the first human implantation of its ultraminiaturized intraocular pressure sensor, which has also received FDA Breakthrough Device designation. This implantable sensor is designed to provide continuous and minimally invasive pressure monitoring, allowing clinicians and patients to track glaucoma progression more accurately and adjust treatment strategies with greater precision. The device enables reliable real-time data collection while minimizing patient discomfort. Such innovations support consistent monitoring, early detection of intraocular pressure fluctuations, and improved long-term disease management, thereby contributing to better clinical outcomes for patients with glaucoma.

What Are Latest Mergers And Acquisitions In The Implantable Pressure Sensor Market?

In November 2023, Millar Inc, a US-based pressure sensor technology and catheters manufacturer acquired Sentron from Siemens for an undisclosed amount. Through this acquisition, Millar expands its capabilities in precision sensor design and manufacturing, strengthening its position in medical and industrial pressure sensing, including technologies used for implantable applications. Sentron Netherlands-based company that provides specialized sensor technology that is used in implantable pressure sensor applications.

What Defines the Implantable Pressure Sensor Market?

The implantable pressure sensor market consists of sales of telemetry devices, catheter-based pressure sensors, and sensor implants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Implantable Pressure Sensor Market Report 2026?

The implantable pressure sensor market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the implantable pressure sensor industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.